Erbitux for advanced colorectal cancerBristol-Myers Squibb is introducing Erbitux, a recombinant monoclonal antibody used for colorectal and head/neck cancers. New drugs available to replace discontinued restless leg treatment LETTER: Fragmentation of patient care would tear away at family practice Once-daily drug maintains remission in ulcerative colitis An exchange of compassion and understanding Fostering an honest relationship with patients not only results in better care for them but also helps them appreciate a doctor’s life NBMS hush about contract talks Billing number restrictions continue to vex doctor supply: president Therapy hastens healing of severe Crohn’s lesions Hospital on hook for maintaining equipment Pregnancy occurred after tubal ligation tools not maintained properly, but MD not at fault Alzheimer’s drug targeting beta amyloid fails in phase III trial Risk of infection noted for etanercept First Previous 1266 1267 1268 1269 1270 Next Last
